Infective endocarditis, Infectious diseases health services research, Substance use and infectious diseases
BA with honors: Wesleyan University, 2007; MD: Perelman School of Medicine at the University of Pennsylvania, 2013; Internship and Residency: New York University, 2016; Fellowship, University of North Carolina, 2018; MPH in Epidemiology: Gillings School of Global Public Health at the University of North Carolina, 2019.
Clinical and Research Interests
Dr. Schranz’s clinical interests include endovascular infections, viral hepatitis and HIV. He is also interested in caring for infectious diseases in persons with substance use disorders.
His research is broadly focused on the intersection of infectious diseases and substance use disorders. He utilizes large datasets to study invasive infections – such as infective endocarditis and bone, joint and spine infections – affecting people who inject drugs, in both North Carolina and the US. Dr. Schranz’s work aims to describe the incidence of such infections and characterize patient outcomes. Therefore, his work also focuses on improving the care of patients hospitalized with severe infections in North Carolina, including determining how best to deliver addiction treatment and harm reduction services.
Dr. Schranz is also interested in Hepatitis C epidemiology as well as clinical practice issues related to the delivery of outpatient parenteral antimicrobial therapy (OPAT).
His work draws on epidemiologic and health services research methods and he regularly partners with collaborators in public health, cardiac surgery and behavioral science.
- Schranz AJ. A Wake-Up Call: Outcomes Following Infective Endocarditis in Persons Who Inject Drugs. Clinical Infectious Diseases. 2019 Sep 3. pii: ciz875. doi: 10.1093/cid/ciz875. [Epub ahead of print]. PMID 31504337.
- Schranz AJ, Davy-Mendez T, Eron JJ, Napravnik S. Opioid misuse and viral suppression among persons with HIV engaged in care in the Southeastern US. AIDS Care. 2019 Dec 8:1-6. doi: 10.1080/09540121.2019.1699644. [Epub ahead of print] PMID: 31814449
- Mori M, Bin Mahmood SU, Schranz AJ, Sultan I, Axtell A, Sarsour N, Hiesinger W, Boskovski M, Hirji S, Kaneko T, Woo J, Tang P, Jassar AS, Atluri P, Whitson B, Gleason T, G Atluri, P, Axtell A, Boskovski M, Gleason TG, Geirsson A. Risk of Redo Valve Surgery for Endocarditis Associated with Illicit Drug Use: report from Multicenter Surgical Endocarditis Collaborative. Journal of Thoracic and Cardiovascular Surgery. 2019 Jul 10. pii: S0022-5223(19)31350-9. PMID 31420136.
- Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: A study of statewide discharge data. Annals of Internal Medicine. 2019;170(1):31-40. PMID 30508432. PMCID PMC6548681.
- Schranz AJ, Barrett J, Malvestutto C, Hurt CB, Miller WC. Challenges facing a rural opioid epidemic: treatment and prevention of HIV and hepatitis C. Current HIV/AIDS Reports. 2018 Jun;15(3):245-254. PMID 29796965. PMCID PMC6085134.
- Schranz AJ, Brady KA, Momplaisir F, Metlay JP, Yehia BR. Comparison of HIV outcomes for patients linked at hospital versus community-based clinics. AIDS Patient Care and STDS. 2015 Mar;29(3):117-25.
- Yehia BR, Schranz AJ, Umscheid CA, Lo Re V. The treatment cascade for people with chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLOS One. 2014 Jul 2;9(7):e101554.